InSitu Technologies Inc.


Siro™ Drug Eluting Stent

Siro™ drug eluting stent sets the bar high.

The Siro Drug Eluting Stent combines the U.S. patented Direct-Stent® design, the proven success of Sirolimus drug to reduce tissue ingrowth and proliferation, leading to reduced restenosis.

Quality-Focused Engineering

  • Trusted and tested strength of a hybrid cell design
  • Patented and proven Direct-Stent platform
  • Clinically proven bioabsorbable polymer 
  • Crimped profile 0.9 – 1.2mm 
  • Semi-compliant balloon material 
  • Results driven Everolimus drug 
  • Rapid Exchange delivery system 
Close Menu